Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
Peer Reviewed
See detailAnticoherence measures for pure spin states
Baguette, Dorian ULiege; Martin, John ULiege

in Physical Review A (2017), 96

The set of pure spin states with vanishing spin expectation value can be regarded as the set of the less coherent pure spin states. This set can be divided into a finite number of nested subsets on the ... [more ▼]

The set of pure spin states with vanishing spin expectation value can be regarded as the set of the less coherent pure spin states. This set can be divided into a finite number of nested subsets on the basis of higher order moments of the spin operators. This subdivision relies on the notion of anticoherent spin state to order t : A spin state is said to be anticoherent to order t if the moment of order k of the spin components along any directions are equal for k = 1,2, . . . ,t . Most spin states are neither coherent nor anticoherent, but can be arbitrary close to one or the other. In or- der to quantify the degree of anticoherence of pure spin states, we introduce the notion of anticoherence measures. By relying on the mapping between spin-j states and symmetric states of 2j spin 1/2 (Majorana representation), we present a systematic way of constructing anticoherence measures to any order. We briefly discuss their connection with measures of quantum coherence. Finally, we illustrate our measures on various spin states and use them to investigate the problem of the existence of anticoherent spin states with degenerated Majorana points. [less ▲]

Detailed reference viewed: 27 (0 ULiège)
Full Text
Peer Reviewed
See detailAnticoherence measures for spin states
Baguette, Dorian ULiege; Martin, John ULiege

Poster (2017, March 09)

Among all possible spin states, spin-coherent states are the most classical because the spin expectation value in these states yields a vector of maximal norm pointing in a well defined direction. In ... [more ▼]

Among all possible spin states, spin-coherent states are the most classical because the spin expectation value in these states yields a vector of maximal norm pointing in a well defined direction. In contrast, anticoherent spin state to order t are such that <(J.n)^k> is independent of the unit vector n for k = 1, ..., t [1]. By construction, coherent and anticoherent spin states are at both ends of the spectrum of classicality. The aim of this work is to position all possible spin states on such a spectrum, that is to provide measures of anticoherence. To this aim, we introduce an axiomatic definition of anticoherence measures to any order t. In particular, we show that the total variance of a pure spin state, first introduced in [2] can be used to define a measure of anticoherence to order 1. We describe a systematic way of constructing anticoherence measures to any order that relies on the mapping between spin-j states and symmetric states of N = 2j spin-1/2. In particular, we exploit the fact that anticoherent spin states to order t have maximally mixed t-spin-1/2 reduced density matrices in the symmetric subspace [3]. [1] J. Zimba, Electron. J. Theor. Phys. 3, 143 (2006). [2] A. A. Klyachko, B. Öztop, and A. S. Shumovsky, Phys. Rev. A 75, 032315 (2007). [3] D. Baguette, T. Bastin, and J. Martin, Phys. Rev A 90, 032314 (2014). [less ▲]

Detailed reference viewed: 40 (8 ULiège)
See detailAnticoherence of multiqubit symmetric states
Baguette, Dorian ULiege; Bastin, Thierry ULiege; Martin, John ULiege

Conference (2015, May 13)

Detailed reference viewed: 38 (1 ULiège)
Full Text
Peer Reviewed
See detailAnticoherence of spin states with point-group symmetries
Baguette, Dorian ULiege; Damanet, François ULiege; Giraud, Olivier et al

Poster (2016, May 18)

Detailed reference viewed: 36 (12 ULiège)
Full Text
Peer Reviewed
See detailAnticoherence of spin states with point-group symmetries
Baguette, Dorian ULiege; Damanet, François ULiege; Giraud, Olivier et al

Poster (2016, March 02)

We investigate multiqubit permutation-symmetric states with maximal entropy of entanglement. Such states can be viewed as particular spin states, namely anticoherent spin states. Using the Majorana ... [more ▼]

We investigate multiqubit permutation-symmetric states with maximal entropy of entanglement. Such states can be viewed as particular spin states, namely anticoherent spin states. Using the Majorana represen- tation of spin states in terms of points on the unit sphere, we analyze the consequences of a point-group symmetry in their arrangement on the quantum properties of the corresponding state [1]. We focus on the identi cation of anticoherent states (for which all reduced density matrices in the symmetric subspace are maximally mixed) associated with point-group-symmetric sets of points. We provide three di erent characterizations of anticoherence and establish a link between point symmetries, anticoherence, and classes of states equivalent through stochastic local operations with classical communication. We then in- vestigate in detail the case of small numbers of qubits and construct in nite families of anticoherent states with point-group symmetry of their Majorana points, showing that anticoherent states do exist to arbitrary order. [1] D. Baguette et al., Phys. Rev. A 92, 052333 (2015). [less ▲]

Detailed reference viewed: 21 (6 ULiège)
Full Text
Peer Reviewed
See detailAnticoherence of spin states with point-group symmetries
Baguette, Dorian ULiege; Damanet, François ULiege; Giraud, Olivier et al

in Physical Review A (2015), 92

We investigate multiqubit permutation-symmetric states with maximal entropy of entanglement. Such states can be viewed as particular spin states, namely anticoherent spin states. Using the Majorana ... [more ▼]

We investigate multiqubit permutation-symmetric states with maximal entropy of entanglement. Such states can be viewed as particular spin states, namely anticoherent spin states. Using the Majorana representation of spin states in terms of points on the unit sphere, we analyze the consequences of a point-group symmetry in their arrangement on the quantum properties of the corresponding state. We focus on the identification of anticoherent states (for which all reduced density matrices in the symmetric subspace are maximally mixed) associated with point-group-symmetric sets of points. We provide three different characterizations of anticoherence and establish a link between point symmetries, anticoherence, and classes of states equivalent through stochastic local operations with classical communication. We then investigate in detail the case of small numbers of qubits and construct infinite families of anticoherent states with point-group symmetry of their Majorana points, showing that anticoherent states do exist to arbitrary order. [less ▲]

Detailed reference viewed: 31 (5 ULiège)
Peer Reviewed
See detailAnticonvulsant properties of 4-cycloalkylamino-pyrid-3-yl sulfonylureas and -thioureas
Masereel, B.; Lambert, D.; Bia, F. et al

in Journal de Pharmacie de Belgique (1996), 51

Detailed reference viewed: 13 (2 ULiège)
Peer Reviewed
See detailAnticonvulsant properties of 4-cycloalkylamino-pyrid-3-yl sulfonylureas and -thioureas
Masereel, B.; Lambert, D.; Bia, F. et al

Poster (1995, June)

Detailed reference viewed: 5 (0 ULiège)
Full Text
Peer Reviewed
See detailAnticorps anti-gliadines déamidées et maladie coeliaque : données actuelles et évaluation des faux positifs de cinq trousses de dosage
Lutteri, Laurence ULiege; Sagot, Laurence; Chapelle, Jean-Paul ULiege

in Annales de Biologie Clinique (2010), 68(2), 149-56

Recently, anti-deamidated gliadin antihodies were proposed for the serological diagnosis of celiac disease. We evaluate the specificity of different anti-deamidated gliadin antibodies ELISA in comparison ... [more ▼]

Recently, anti-deamidated gliadin antihodies were proposed for the serological diagnosis of celiac disease. We evaluate the specificity of different anti-deamidated gliadin antibodies ELISA in comparison with conventional anti-native gliadin kits. Serum sainples froin 46 non celiac patients trere analyzed by five different quantitative ELISA for anti-native gliadin, antideamidated gliadin and anti-fransglutaininase neo-epitope antibodies together with a screening ELISA. Twenty-four percent of the patients deinonstrated anti-native gliadin lgA and 63% 1gO antibodies. Using anti-dearnidated gliadin antibodies, tire number of false positive IgA and, particularly, 1gG results,markedly decreased in the non celiac patients: 21 and 24% respectively with anti-Gliadin (GAF-3X) Euroimmun kit, 7 and 26% with Bindazyme 1-lurnan Anti-Gliadin (MGP) The Binding Site kit and 0 and 41% with Celiac G+ Immco kit. The new assay which makes use of the physiological complex of tissue transglutaminase cross-linked with deamidated gliadin peptides, called neo-epitope, did not improve the differential diagnosis of celiac disease with 30% of false positive results in IgG (2% in IgA). IJsing the Inova screening kit, a positive resuit for IgA and/or IgG anti-deamidated gliadin and!or anti- tissue transglutaminase antibodies was obtained in 24% of the non celiac patients. In conclusion, our study assessed the superiority, in ternis of specificity, of anti-deamidated gliadin antibodies, over the conventional anti-gliadin antibodies for die differential diagnosis of celiac disease. [less ▲]

Detailed reference viewed: 862 (18 ULiège)
See detailLes anticorps anti-nucléaires : stratégies de recherche et nouveautés cliniques en 2015
LUTTERI, Laurence ULiege

Scientific conference (2015, April 23)

Detailed reference viewed: 12 (0 ULiège)
See detailLes anticorps anti-nucléaires
LUTTERI, Laurence ULiege

Conference (2015, March 07)

Detailed reference viewed: 13 (0 ULiège)
Peer Reviewed
See detailAnticorps anticytoplasme des polynucléaires neutrophiles (ANCA) dans les maladies inflammatoires du tube digestif
Lamproye, Anne ULiege; Belaiche, Jacques ULiege; Louis, Edouard ULiege et al

in Acta Gastro-Enterologica Belgica (1994), 57(2, Mar-Apr), 171-6

Antineutrophil cytoplasmic antibodies have recently been demonstrated in sera of patients with inflammatory bowel disease. We are reporting here our experience among 94 patients with Crohn's disease and ... [more ▼]

Antineutrophil cytoplasmic antibodies have recently been demonstrated in sera of patients with inflammatory bowel disease. We are reporting here our experience among 94 patients with Crohn's disease and 25 with ulcerative colitis. The indirect immunofluorescence assay with alcohol fixed neutrophils has been used. The presence of antineutrophil cytoplasmic antibodies was significantly associated to the ulcerative colitis 61% VS 17% (p < 0.001). The fluorescence had a perinuclear pattern among all but one suffering from ulcerative colitis. Among the patients suffering from ulcerative colitis there was no relationship between the presence of antineutrophil cytoplasmic antibodies and the activity or the localisation of the disease. Among the 9 patients operated for their ulcerative colitis, 4 were ANCA positive and remained so after proctocolectomy. The existence of antineutrophil cytoplasmic antibodies is useful for the diagnosis of some unclassifiable colitis. Their presence may be used as an argument in favour of some disturbances of the immunoregulation of the disease. [less ▲]

Detailed reference viewed: 180 (0 ULiège)
Full Text
Peer Reviewed
See detailLes anticorps hétérophiles : une cause souvent méconnue d'erreurs de diagnostic
Cavalier, Etienne ULiege; Delanaye, Pierre ULiege; Beckers, Albert ULiege

in 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010 (2010, September)

Detailed reference viewed: 231 (0 ULiège)
Full Text
Peer Reviewed
See detailLes anticorps hétérophiles : une cause souvent méconnue d'erreurs de diagnostic
Cavalier, Etienne ULiege; Carlisi, A.; Delanaye, Pierre ULiege et al

in Annales d'Endocrinologie (2010, September), 71(5), 367-68

Detailed reference viewed: 18 (0 ULiège)
Full Text
Peer Reviewed
See detailAnticorps monoclonaux a usage therapeutique en hemato-oncologie. Generalites.
Gennigens, Christine ULiege; Collignon, Joëlle ULiege; Jerusalem, Guy ULiege et al

in Revue Médicale de Liège (2009), 64(5-6), 264-7

For many years, chemotherapy, hormonotherapy and immunotherapy were the mainstay of cancer treatment. Recent advances in our knowledge of cell biology and particularly of cancer cell transformation ... [more ▼]

For many years, chemotherapy, hormonotherapy and immunotherapy were the mainstay of cancer treatment. Recent advances in our knowledge of cell biology and particularly of cancer cell transformation, growth and metastasis have led to the identification of specific pathways playing a role in the pathophysiology of cancer. New drugs specifically developed to control these targets are collectively named "targeted therapies". Two types of targeted therapies are available: kinase (mainly tyrosine kinase) inhibitors (suffix -nib) are small molecules binding directly to the intracellular kinase domain and acting as competitive inhibitor of ATP binding and monoclonal antibodies (suffix -mab) directed towards specific cell surface receptors or their ligands to prevent receptor activation. This paper will only review monoclonal antibodies (mabs). Thirty years after their discovery mAbs have become efficient therapeutic tools. Progress in molecular engineering as well as improved knowledge of cell signalling pathways together with a better selection of the targets turned them into valuable treatments. Several mAbs are currently licensed for the treatment of hematological or solid malignancies and many others are expected in the near future. [less ▲]

Detailed reference viewed: 143 (1 ULiège)
Full Text
Peer Reviewed
See detailAnticorps monoclonaux en cardiologie.
Legrand, Victor ULiege

in Revue medicale de Liege (2009), 64(5-6), 310-2

Clinical efficacy of antiplatelet agents administration to reduce ischemic complications has supported the concept of atherothrombosis and plaque rupture. Specifically, administration of monoclonal ... [more ▼]

Clinical efficacy of antiplatelet agents administration to reduce ischemic complications has supported the concept of atherothrombosis and plaque rupture. Specifically, administration of monoclonal antibody against platelet membrane receptor glycoprotein IIb/IIa was shown to be highly effective whenever percutaneous intervention is performed in the setting of unstable coronary syndrome. The in-hospital use of glycoprotein IIb/IIIa is unanimously recommended in these situations. [less ▲]

Detailed reference viewed: 24 (0 ULiège)
Full Text
Peer Reviewed
See detailAnticorps monoclonaux en diabétologie : jusqu’au bout du rêve ?
Philips, Jean-Christophe ULiege; Keymeulen, B.; Mathieu, C. et al

in Revue Médicale de Liège (2009), 64(5-6), 3327-333

SUMMARY : Type 1 diabetes is characterized by the autoimmune- mediated destruction of the insulin-producing beta cells of the pancreatic islets of Langerhans. Several cells are potentially implicated in ... [more ▼]

SUMMARY : Type 1 diabetes is characterized by the autoimmune- mediated destruction of the insulin-producing beta cells of the pancreatic islets of Langerhans. Several cells are potentially implicated in the selective destruction of beta cells, including the beta cells themselves, and T-lymphocytes and B- lymphocytes that are working as antigen-presenting cells. Both types of lymphocytes play also a role in the progressive loss of graft function after islet transplantation. Therefore, immunotherapy may represent a great opportunity to prevent, treat or even cure type 1 diabetes, and the input of monoclonal antibodies (mAb) appears crucial in such a strategy. The concept has first been validated in various animal models, especially the classical one of the NOD mouse. During recent years, promising results of a few clinical trials have been published with the administration of anti-CD3 mAbs targeting T lymphocytes at the time of diagnosis of type 1 diabetes. Results showed a more sustained residual insulin secretion during the following months associated with a reduction in insulin needs. Interesting results may also be expected from the use of anti-CD20 mAbs targeting B lymphocytes. Finally, when considering immunosuppressive therapies after beta-cell transplantation, mAbs, especially those blocking interleukin-2, are already used in clinical practice, but new trials are expected with mAbs targeting T or B lymphocytes. Thus, mAbs might be efficacious in a near future in the prevention (when administered early in the natural course of the disease, in high risk patients) and the treatment of type 1 diabetes, and therefore could avoid, or at least minimize, the constraints of intensive subcutaneous insulin therapy. [less ▲]

Detailed reference viewed: 224 (4 ULiège)